• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描和磁共振弥散加权成像在评估胃肠道恶性肿瘤腹膜转移中的应用。

Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.

机构信息

Department of Nuclear Medicine, Université Paris 13, CHU Avicenne, 125 rue de Stalingrad, 93000, Bobigny, France.

出版信息

Eur Radiol. 2012 Jul;22(7):1479-87. doi: 10.1007/s00330-012-2397-2. Epub 2012 Feb 24.

DOI:10.1007/s00330-012-2397-2
PMID:22358428
Abstract

OBJECTIVES

To assess the accuracy of FDG-PET/CT and MR with diffusion-weighted imaging (MR-DWI) for diagnosing peritoneal carcinomatosis (PC) from gastrointestinal malignancies.

METHODS

Thirty consecutive patients referred for staging of gastrointestinal malignancy underwent FDG-PET/CT and MR-DWI in this retrospective study. Extent of PC was characterised by dividing the peritoneal cavity into three sites in each patient: right and left supramesocolic areas and inframesocolic level (total 90 sites). Presence of PC was confirmed either by surgery (18/30) or by follow-up (12/30).

RESULTS

PC was confirmed in 19 patients (19/30). At a total of 90 sites, 27 showed proven PC. On a patient-based analysis, sensitivity, specificity, PPV, NPV and accuracy were respectively 84%, 73%, 84%, 73% and 80% for PET/CT and 84%, 82%, 89%, 75% and 83% for MR-DWI. On a site-based analysis, overall sensitivity and specificity of PET/CT (63%, 90%) and MR-DWI (74%, 97%) were not statistically different (P = 0.27). In the supramesocolic area, MR-DWI detected more sites involved than PET/CT (7/9 vs. 4/9). The sensitivities of PET and MR were lower for subcentimetre tumour implants (42%, 50%). Interobserver agreement was very good for PET/CT and good for MR-DWI.

CONCLUSIONS

FDG-PET/CT and MR-DWI showed similar high accuracy in diagnosing PC. Both techniques underestimated the real extent of PC because of decreased sensitivity for subcentimetre lesions.

KEY POINTS

FDG-PET/CT and MR-DWI showed similar high accuracy for diagnosing peritoneal carcinomatosis. • In the supramesocolic area, MR-DWI could be more sensitive than PET/CT. • Both techniques showed lower sensitivity for subcentimetre lesions. • Interobserver agreement was very good for PET/CT and good for MR-DWI.

摘要

目的

评估氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)与磁共振弥散加权成像(MR-DWI)诊断胃肠道恶性肿瘤腹膜转移(PC)的准确性。

方法

本回顾性研究纳入了 30 例连续就诊于胃肠道恶性肿瘤的患者,他们均接受了 FDG-PET/CT 和 MR-DWI 检查。在每位患者中,将腹膜腔分为三个部位:右、左上腹腔和中腹腔(共 90 个部位),对 PC 的程度进行了特征描述。通过手术(18/30)或随访(12/30)确定 PC 的存在。

结果

19 例患者(19/30)被证实患有 PC。在总共 90 个部位中,27 个部位证实存在 PC。基于患者的分析,PET/CT 的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为 84%、73%、84%、73%和 80%,MR-DWI 的相应值分别为 84%、82%、89%、75%和 83%。基于部位的分析显示,PET/CT(63%,90%)和 MR-DWI(74%,97%)的总体敏感性和特异性无统计学差异(P=0.27)。在上腹腔,MR-DWI 检测到的受累部位多于 PET/CT(7/9 比 4/9)。PET 和 MR 对亚厘米肿瘤种植的敏感性较低(42%,50%)。PET/CT 和 MR-DWI 的观察者间一致性均非常好。

结论

FDG-PET/CT 和 MR-DWI 在诊断 PC 方面具有相似的高准确性。由于对亚厘米病变的敏感性降低,两种技术均低估了 PC 的真实程度。

关键点

FDG-PET/CT 和 MR-DWI 对诊断腹膜转移具有相似的高准确性。在腹腔,MR-DWI 可能比 PET/CT 更敏感。两种技术对亚厘米病变的敏感性较低。PET/CT 和 MR-DWI 的观察者间一致性均非常好。

相似文献

1
Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.比较氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描和磁共振弥散加权成像在评估胃肠道恶性肿瘤腹膜转移中的应用。
Eur Radiol. 2012 Jul;22(7):1479-87. doi: 10.1007/s00330-012-2397-2. Epub 2012 Feb 24.
2
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.18F-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像在淋巴瘤中的应用:与18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的比较以及添加磁共振扩散加权成像的研究
Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.
3
Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.腹膜癌患者同时进行磁共振成像/正电子发射断层扫描测量表观扩散系数:与18F-FDG-PET的比较
J Magn Reson Imaging. 2014 Nov;40(5):1121-8. doi: 10.1002/jmri.24497. Epub 2013 Nov 8.
4
Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.全身磁共振弥散加权序列在疑似卵巢癌患者分期中的临床可行性研究:与 CT 和 FDG-PET/CT 的比较。
Eur Radiol. 2014 Apr;24(4):889-901. doi: 10.1007/s00330-013-3083-8. Epub 2013 Dec 11.
5
Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.使用3T MR系统的快速自旋回波(FASE)序列进行扩散加权磁共振成像:通过使用回波平面成像(EPI)序列的扩散加权磁共振成像、短TI反转恢复快速自旋回波(STIR FASE)成像和氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)对非小细胞肺癌患者进行N分期评估能力的初步比较。
Eur J Radiol. 2015 Nov;84(11):2321-31. doi: 10.1016/j.ejrad.2015.07.019. Epub 2015 Jul 26.
6
Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.扩散加权磁共振成像与整合 [¹⁸F]-FDG PET/CT 在肺癌患者 N 分期中的比较。
Eur J Radiol. 2012 Jan;81(1):178-82. doi: 10.1016/j.ejrad.2010.09.001. Epub 2010 Oct 6.
7
Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.转移性胃肠道间质瘤(GIST)的扩散加权磁共振成像:与18F-FDG PET/CT相比评估治疗反应的一项初步研究
Acta Radiol. 2013 Oct;54(8):837-42. doi: 10.1177/0284185113485732. Epub 2013 May 9.
8
Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.弥散加权成像在局部进展期直肠癌新辅助放化疗后检测肿瘤活性中的价值:与 T2 加权成像和 PET/CT 成像的比较。
Br J Radiol. 2012 May;85(1013):577-86. doi: 10.1259/bjr/68424021. Epub 2011 Feb 22.
9
Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.使用F-18-FDG-PET/CT评估细胞减灭术和热灌注腹腔化疗后腹膜癌患者的复发情况。
Rofo. 2014 Apr;186(4):359-66. doi: 10.1055/s-0034-1366041. Epub 2014 Mar 28.
10
Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.在专用全身磁共振/正电子发射断层扫描系统中对肺部病变进行同时采集的弥散加权成像和 2-脱氧-[18F]氟-2-D-葡萄糖正电子发射断层扫描的相关性研究。
Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

引用本文的文献

1
Head-to-head comparison of Ga-FT-FAPI with Ga-FAPI-04 in patients with gastrointestinal tumors.镓标记的FT-FAPI与镓标记的FAPI-04在胃肠道肿瘤患者中的头对头比较。
Eur J Nucl Med Mol Imaging. 2025 Jun 4. doi: 10.1007/s00259-025-07372-2.
2
What is the accuracy, sensitivity and specificity of the radiological peritoneal cancer index in repeat cytoreductive surgery: a retrospective study.重复细胞减灭术中放射学腹膜癌指数的准确性、敏感性和特异性:一项回顾性研究
World J Surg Oncol. 2025 Apr 11;23(1):138. doi: 10.1186/s12957-025-03775-5.
3
An Assessment of the Effectiveness of Preoperative İmaging Modalities (MRI, CT, and 18F-FDG PET/CT) in Determining the Extent of Disease Spread in Epithelial Ovarian-Tubal-Peritoneal Cancer (EOC).

本文引用的文献

1
Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.腹膜播散的诊断:18F-FDG PET/CT、扩散加权 MRI 和对比增强 MDCT 的比较。
AJR Am J Roentgenol. 2011 Feb;196(2):447-53. doi: 10.2214/AJR.10.4687.
2
Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.在腹腔热灌注化疗前使用氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG-PET/CT)诊断腹膜癌病
Nucl Med Commun. 2011 Jan;32(1):23-9. doi: 10.1097/MNM.0b013e328340e730.
3
Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer.
术前影像检查方式(MRI、CT和18F-FDG PET/CT)在确定上皮性卵巢-输卵管-腹膜癌(EOC)疾病扩散范围中的有效性评估
Medicina (Kaunas). 2025 Jan 23;61(2):199. doi: 10.3390/medicina61020199.
4
The role of multimodality imaging in the selection and management of patients treated with cytoreductive surgery and HIPEC.多模态影像学在细胞减灭术和 HIPEC 治疗患者的选择和管理中的作用。
Abdom Radiol (NY). 2024 Dec;49(12):4352-4364. doi: 10.1007/s00261-024-04441-2. Epub 2024 Jul 8.
5
Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.FAPI PET 成像在胃癌中的评估:系统评价和荟萃分析。
Theranostics. 2023 Aug 21;13(13):4694-4710. doi: 10.7150/thno.88335. eCollection 2023.
6
CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis.预测伴有同步腹膜转移的胃癌预后的CT特征
Front Oncol. 2023 Jan 11;12:1061806. doi: 10.3389/fonc.2022.1061806. eCollection 2022.
7
Prospective Comparison of the Performance of MRI Versus CT in the Detection and Evaluation of Peritoneal Surface Malignancies.MRI与CT在检测和评估腹膜表面恶性肿瘤方面性能的前瞻性比较。
Cancers (Basel). 2022 Jun 29;14(13):3179. doi: 10.3390/cancers14133179.
8
Diagnostic performance of [F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis.[F]-FDG PET/MR 在评估结直肠癌中的诊断性能:系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4205-4217. doi: 10.1007/s00259-022-05871-0. Epub 2022 Jun 16.
9
Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task force.多中心 DWI-MR 成像中跨供应商变异性的量化和减少:癌症核心欧洲成像工作组的结果。
Eur Radiol. 2022 Dec;32(12):8617-8628. doi: 10.1007/s00330-022-08880-7. Epub 2022 Jun 9.
10
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.镓-68 标记的成纤维细胞激活蛋白抑制剂 PET 在胃肠癌中的应用:诊断和治疗的新视角。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4228-4240. doi: 10.1007/s00259-022-05847-0. Epub 2022 Jun 3.
腹膜疾病的弥散加权成像在晚期卵巢癌的无创分期中的应用。
Radiographics. 2010 Sep;30(5):1269-85. doi: 10.1148/rg.305105073.
4
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques.使用 4D-PET/CT 呼吸门控采集技术检测和补偿器官/病变运动。
Radiother Oncol. 2010 Sep;96(3):311-6. doi: 10.1016/j.radonc.2010.07.014. Epub 2010 Aug 12.
5
Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values.比较不同 b 值的常规磁共振成像和扩散加权磁共振成像在腹膜肿瘤成像中的应用。
Eur J Radiol. 2011 Nov;80(2):224-8. doi: 10.1016/j.ejrad.2010.06.004. Epub 2010 Jul 3.
6
Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study.腹膜肿瘤的扩散加权磁共振成像:与传统磁共振成像及手术和组织病理学结果的比较——一项可行性研究
AJR Am J Roentgenol. 2009 Aug;193(2):461-70. doi: 10.2214/AJR.08.1753.
7
Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values.肝脏病变的呼吸触发与屏气扩散加权磁共振成像:图像质量与表观扩散系数值的比较
AJR Am J Roentgenol. 2009 Apr;192(4):915-22. doi: 10.2214/AJR.08.1260.
8
(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.利用(18)F-FDG-PET/CT 来选择适合进行细胞减灭术和腹腔热灌注化疗的腹膜癌转移患者。
Ann Surg Oncol. 2009 May;16(5):1295-303. doi: 10.1245/s10434-009-0387-7. Epub 2009 Feb 28.
9
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.背景体部信号抑制的扩散加权全身成像(DWIBS):肿瘤学中的特征及潜在应用
Eur Radiol. 2008 Sep;18(9):1937-52. doi: 10.1007/s00330-008-0968-z. Epub 2008 Apr 30.
10
Recommendations on the use of 18F-FDG PET in oncology.关于18F-FDG PET在肿瘤学中应用的建议。
J Nucl Med. 2008 Mar;49(3):480-508. doi: 10.2967/jnumed.107.047787. Epub 2008 Feb 20.